US Stock MarketDetailed Quotes

COGT Cogent Biosciences

Watchlist
  • 8.580
  • -0.310-3.49%
Close Aug 9 16:00 ET
  • 9.000
  • +0.420+4.90%
Post 20:02 ET
939.08MMarket Cap-3445P/E (TTM)

Cogent Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cogent Biosciences Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.59

0.00%
Analyst Rating

Strong Buy

Aug 11, 2024

Cogent Biosciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Cogent Biosciences Earnings Reports

  • Cogent Biosciences | 10-Q: Q2 2024 Earnings Report

    Aug 6 08:43 ET

  • Cogent Biosciences | 10-Q: Q1 2024 Earnings Report

    May 7 08:29 ET

  • Cogent Biosciences | 10-K: FY2023 Annual Report

    Feb 26 09:15 ET

  • Cogent Biosciences: Q3 2023 Earnings Report

    Nov 7, 2023 07:27 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 11, 2024

    Strong Buy

    • Buy

      88.89%

    • Hold

      11.11%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg